The abstract is read at the publisher; the summary is JClub's.
Dysregulated glycolysis is strongly associated with type 2 diabetes and increased cancer risk, with shared metabolic disruptions linked to harmful stress pathways across multiple cell types.
- Why it matters: The work addresses the gap in explaining how type 2 diabetes and cancer risk are connected, focusing on overlapping metabolic disruptions that may contribute to both disease processes.
- What they did: It reviews evidence that chronic hyperglycemia alters glycolytic flux, causing toxic intermediate accumulation and oxidative/glycative stress, and it compares shared enzyme and pathway shifts in cancer.
- The result: The synthesis suggests glycolysis-related abnormalities could serve as a mechanistic link and supports pharmacological strategies aimed at balanced metabolic modulation common to both conditions.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.